All In Biotech

Drug Trial Radar · NCT07156578

A Long-Term Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

A Long-Term, Open-Label Extension Study of Bivamelagon in Participants With Hypothalamic Obesity (HO)

Last checked: Nov 19, 2026Latest source record: Feb 10, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Enrolling by invitation

Status

Enrolling by invitation

Enrollment

25

Planned (sponsor's estimate)

Start

Nov 10, 2025

Primary completion

Apr 15, 2028

Study completion Apr 15, 2028

Sponsor

Lead sponsor
Rhythm Pharmaceuticals, Inc.Industry
Sponsor type
Industry
First posted
Sep 5, 2025

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 2
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 12 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a long-term, open-label extension study of bivamelagon in participants with Hypothalamic Obesity (HO) who have transitioned from the index study, LG-MCCL005. The study will last up to 2 years.

Conditions

  • Hypothalamic Obesity

Interventions

  • BivamelagonDrug

    daily dose of oral bivamelagon

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Safety and tolerability of bivamelagon as assessed by the number and frequency of AEsTime frame: Baseline to up to 2 years

Locations

9 sites in 2 countries. Site status is shown where the registry gives one.

  • Children's Hospital Colorado

    Aurora, Colorado

  • University of Iowa Children's Hospital

    Iowa City, Iowa

  • Tufts Medical Center

    Boston, Massachusetts

  • Columbia University

    New York, New York

  • The University of North Carolina at Chapel Hill

    Chapel Hill, North Carolina

  • St. Jude Children's Research Hospital

    Memphis, Tennessee

  • Birmingham Women's and Children's NHS Foundation Trust

    Birmingham, United Kingdom

  • University of Cambridge

    Cambridge, United Kingdom

  • Great Ormond Street Hospital for Children

    London, United Kingdom

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.